Jump to section
To use data to deliver good health for all.
Few candidates hear
back within 2 weeks
37% female employees
24% employee growth in 12 months
Huma is a global digital health technology company that advances digital-first care delivery and research through its award-winning modular platforms.
The company got an early boost after gaining the interest of Apple, which tasked Huma with developing a chemotherapy app for the Apple Watch. Since then, the company's various platforms are used by over 3,000 hospitals and clinics, with over 1.8+ million active healthcare users and 650,000+ research participants.
Its modular approach has proven highly advantageous, as it affords the company the ability to easily add new products and grow into new markets. Doctors use Huma's technology to monitor patient health across a range of rare and chronic diseases. It also offers symptom tracking, medication adherence, video consultations, and more.
Huma is also focusing on its humanitarian work such as donating resources to India and other countries. The company is well set for growth, especially following its acquisition of Alcedis.
Steph
Company Specialist at Welcome to the Jungle
Jul 2024
$80m
SERIES D
Jan 2023
$0.7m
GRANT
This company has top investors
Dan Vahdat
(CEO)Studied Engineering at John Hopkins University and Oxford University.
Dr Rich Khatib
(Executive Director & Member of the Board)Experienced executive. CEO of a family office, CEO of a consulting firm, VP of a B2B marketplace. Had a PhD in Economics from Oxford University.
Sophia Khan (People Operations Analyst )